News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Warns of Possible Cataract Link With Vertex Pharmaceuticals (MA) (VRTX)'s Kalydeco


8/30/2012 7:47:40 AM

The Food and Drug Administration is warning doctors, parents and patients about the potential for eye disorders linked to Kalydeco, a groundbreaking treatment for cystic fibrosis approved earlier this year. The FDA says the warning is based on cases of cataract seen in juvenile rats studied by the drug's manufacturer, Vertex Pharmaceuticals. The study was designed to show that Kalydeco is safe for children younger than 2 years old. Cataract is a clouding of the eye's lens that can disrupt vision.

Read at CBS News
Read at CNBC
Read at Reuters
Read at Wall Street Journal

comments powered by Disqus
   
Cataract

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES